STAGE III COLON CANCER
Clinical trials for STAGE III COLON CANCER explained in plain language.
Never miss a new study
Get alerted when new STAGE III COLON CANCER trials appear
Sign up with your email to follow new studies for STAGE III COLON CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
DNA-Guided chemo aims to stop colon cancer return
Disease control TerminatedThis study tests whether using a blood test for circulating tumor DNA (ctDNA) can help doctors decide if patients with stage II or III colon cancer need stronger chemotherapy after surgery. The trial compares standard chemo with a more intense regimen (FOLFOXIRI) and an additiona…
Matched conditions: STAGE III COLON CANCER
Phase: PHASE2 • Sponsor: Gruppo Oncologico del Nord-Ovest • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
New drug cocktail aims to stop BRAF colon cancer in its tracks
Disease control OngoingThis study tests whether adding two targeted drugs (encorafenib and cetuximab) after standard surgery and chemotherapy can lower the chance of cancer coming back in people with a specific genetic type of stage II/III colon cancer (BRAF V600E). Participants either receive the drug…
Matched conditions: STAGE III COLON CANCER
Phase: PHASE2, PHASE3 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control
Last updated Jun 27, 2026 08:14 UTC
-
Colon cancer study aims to improve treatment for older patients
Knowledge-focused OngoingThis study follows over 2,000 Korean patients with stage II or III colon cancer after surgery to see which chemotherapy treatments they actually receive and how they fare. Unlike typical clinical trials, it includes older adults and reflects real-world medical practice. The goal …
Matched conditions: STAGE III COLON CANCER
Sponsor: Boryung Pharmaceutical Co., Ltd • Aim: Knowledge-focused
Last updated Jun 26, 2026 15:53 UTC